Should I buy or sell Augmedix stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Augmedix in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AUGX shares. View AUGX analyst ratings or view top-rated stocks .

What is Augmedix's stock price target for 2024?

3 equities research analysts have issued 1-year price objectives for Augmedix's shares. Their AUGX share price targets range from $6.00 to $8.00. On average, they predict the company's stock price to reach $6.83 in the next twelve months. This suggests a possible upside of 15.8% from the stock's current price. View analysts price targets for AUGX or view top-rated stocks among Wall Street analysts .

How have AUGX shares performed in 2023?

Augmedix's stock was trading at $1.56 at the beginning of the year. Since then, AUGX shares have increased by 278.2% and is now trading at $5.90. View the best growth stocks for 2023 here .

How were Augmedix's earnings last quarter?

Augmedix, Inc. (OTCMKTS:AUGX) announced its earnings results on Monday, November, 6th. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.02. The company had revenue of $11.77 million for the quarter, compared to analyst estimates of $11.41 million. Augmedix had a negative trailing twelve-month return on equity of 980.09% and a negative net margin of 57.70%.

How do I buy shares of Augmedix?

Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Augmedix Stock Price, News & Analysis (OTCMKTS:AUGX)

$5.90

+0.24 (+4.24%)

(As of 12/8/2023 ET)

Compare

Today's Range: $5.57
▼
$6.00
50-Day Range: $4.34
▼
$5.90
52-Week Range: $1.01
▼
$6.00

Volume: 407,287 shs
Average Volume: 439,822 shs
Market Capitalization: $244.05 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.83

Stock Analysis Analyst Forecasts Chart Earnings Financials Headlines Insider Trades Ownership SEC Filings

Augmedix MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 15.8% Upside
$6.83 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.48) to ($0.36) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.48 out of 5 stars

2.5

Analyst's Opinion

Consensus Rating
Augmedix has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $6.83, Augmedix has a forecasted upside of 15.8% from its current price of $5.90.
Amount of Analyst Coverage
Augmedix has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for AUGX.

0.0

Dividend Strength

Dividend Yield
Augmedix does not currently pay a dividend.
Dividend Growth
Augmedix does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AUGX.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Augmedix this week, compared to 1 article on an average week.
Search Interest
5 people have searched for AUGX on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Augmedix insiders have not sold or bought any company stock.
Percentage Held by Insiders
10.97% of the stock of Augmedix is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
71.58% of the stock of Augmedix is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Augmedix are expected to grow in the coming year, from ($0.48) to ($0.36) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Augmedix is -10.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Augmedix is -10.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Augmedix has a P/B Ratio of 59.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Augmedix Stock (OTCMKTS:AUGX)

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Notes that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, a self-service mobile software application. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

AUGX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AUGX Stock News Headlines

December 9, 2023 | finance.yahoo.com

Augmedix, Inc. (NASDAQ:AUGX) has caught the attention of hedge funds investors who hold a sizeable 40% stake

November 27, 2023 | msn.com

Augmedix (AUGX) Price Target Increased by 7.60% to 7.82

December 9, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

November 24, 2023 | uk.finance.yahoo.com

Augmedix, Inc. (AUGX)

November 16, 2023 | investorplace.com

Why Is Augmedix (AUGX) Stock Down 27% Today?

November 15, 2023 | finance.yahoo.com

Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common Stock

November 10, 2023 | finance.yahoo.com

How Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%

November 9, 2023 | finance.yahoo.com

Analyst Estimates: Here's What Brokers Think Of Augmedix, Inc. (NASDAQ:AUGX) After Its Third-Quarter Report

December 9, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

November 7, 2023 | finance.yahoo.com

Augmedix, Inc. (NASDAQ:AUGX) Q3 2023 Earnings Call Transcript

October 9, 2023 | finance.yahoo.com

Getting In Cheap On Augmedix, Inc. (NASDAQ:AUGX) Might Be Difficult

October 4, 2023 | msn.com

Augmedix: Using Generative AI To Document Medical Records

September 21, 2023 | finance.yahoo.com

Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be Sustainable

September 12, 2023 | msn.com

Are Medical Stocks Lagging Augmedix (AUGX) This Year?

September 12, 2023 | finance.yahoo.com

Are Medical Stocks Lagging Augmedix (AUGX) This Year?

September 5, 2023 | finance.yahoo.com

Recent Price Trend in Augmedix, Inc. (AUGX) is Your Friend, Here's Why

August 24, 2023 | finance.yahoo.com

Is Artivion (AORT) Outperforming Other Medical Stocks This Year?

August 24, 2023 | finance.yahoo.com

Augmedix Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance

August 18, 2023 | finance.yahoo.com

Augmedix Announces Participation in Upcoming Investor Conferences in September 2023

August 16, 2023 | finance.yahoo.com

Augmedix, Inc. (AUGX) Is a Great Choice for 'Trend' Investors, Here's Why

August 16, 2023 | finance.yahoo.com

Wall Street Analysts See a 32.11% Upside in Augmedix, Inc. (AUGX): Can the Stock Really Move This High?

August 9, 2023 | markets.businessinsider.com

B.Riley Financial Keeps Their Buy Rating on Augmedix (AUGX)

August 8, 2023 | finance.yahoo.com

Why Shares of Augmedix Are Climbing on Tuesday

August 8, 2023 | finanznachrichten.de

Augmedix Inc: Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023

August 8, 2023 | finance.yahoo.com

Augmedix Delivers 47% Revenue Growth and Expanded Gross Margins for Second Quarter of 2023

August 8, 2023 | finance.yahoo.com

Augmedix, Inc. (AUGX) Reports Q2 Loss, Tops Revenue Estimates

August 4, 2023 | benzinga.com

Augmedix's Earnings: A Preview

See More Headlines

Receive AUGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/06/2023
Today: 12/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Health Information Services
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:AUGX
CUSIP: N/A
CIK: 1769804
Web: www.augmedix.com
Phone: 888-669-4885
Fax: N/A
Employees: 1,040
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $6.83
High Stock Price Target: $8.00
Low Stock Price Target: $6.00
Potential Upside/Downside: +15.8%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.51)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-24,450,000.00
Net Margins: -57.70%
Pretax Margin: -57.23%
Return on Equity: -980.09%
Return on Assets: -57.85%

Debt

Debt-to-Equity Ratio: 3.74
Current Ratio: 1.70
Quick Ratio: 1.70

Sales & Book Value

Annual Sales: $40.93 million
Price / Sales: 5.96
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.10 per share
Price / Book: 59.00

Miscellaneous

Outstanding Shares: 41,364,000
Free Float: 36,316,000
Market Cap: $244.05 million
Optionable: Not Optionable
Beta: -0.15

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Emmanuel Krakaris (Age 64)
President, CEO, Secretary & Director
Comp: $734.33k
Mr. Ian Shakil (Age 38)
Founder, Chief Strategy Officer & Director
Ms. Sandra Breber (Age 65)
Chief Operating Officer
Comp: $446.05k
Mr. Saurav Chatterjee Ph.D. (Age 51)
Chief Technology Officer
Comp: $438.05k
Mr. Paul Louis Ginocchio (Age 53)
Chief Financial Officer
Todd Holvick
Head of Legal & Compliance
Lia Wallick
Head of People
Dr. Davin Lundquist M.D.
Chief Medical Officer
Mr. Jonathan Hawkins (Age 53)
Chief Revenue Officer
Comp: $417.71k

Key Competitors

View All Competitors

Insiders

Margie L Traylor
Bought 26,530 shares on 6/14/2023
Total: $119,650.30 ($4.51/share)

View All Insider Transactions

AUGX Stock Analysis - Frequently Asked Questions

Should I buy or sell Augmedix stock right now?: 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Augmedix in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AUGX shares.
View AUGX analyst ratings or view top-rated stocks.
What is Augmedix's stock price target for 2024?: 3 equities research analysts have issued 1-year price objectives for Augmedix's shares. Their AUGX share price targets range from $6.00 to $8.00. On average, they predict the company's stock price to reach $6.83 in the next twelve months. This suggests a possible upside of 15.8% from the stock's current price.
View analysts price targets for AUGX or view top-rated stocks among Wall Street analysts.
How have AUGX shares performed in 2023?: Augmedix's stock was trading at $1.56 at the beginning of the year. Since then, AUGX shares have increased by 278.2% and is now trading at $5.90.
View the best growth stocks for 2023 here.

How were Augmedix's earnings last quarter?: Augmedix, Inc. (OTCMKTS:AUGX) announced its earnings results on Monday, November, 6th. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.02. The company had revenue of $11.77 million for the quarter, compared to analyst estimates of $11.41 million. Augmedix had a negative trailing twelve-month return on equity of 980.09% and a negative net margin of 57.70%.
How do I buy shares of Augmedix?: Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:AUGX) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Augmedix Stock Price, News & Analysis (OTCMKTS:AUGX)

Augmedix MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Augmedix Stock (OTCMKTS:AUGX)

AUGX Stock Price History

AUGX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

AUGX Stock Analysis - Frequently Asked Questions

Overall MarketRank^™